10. Long-term treatment for ACS (English Version)

How can you formulate a long-term plan for an ACS patient before hospital discharge & during follow-up at the OPD?

0:00 Intro
1:52 Cardiac Rehabilitation
3:28 Lifestyle Management
9:44 Pharmacotherapy
22:28 Adherence & Persistence
27:16 Imaging
28:06 Vaccination
28:56 Patient Perspectives
32:03 Finale

2023 ESC Guidelines for the Management of Acute Coronary Syndromes
https://www.escardio.org/Guidelines/C...


2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data
https://oup.silverchair-cdn.com/oup/b...


2021 ESC Guidelines of CVD Prevention
https://www.escardio.org/Guidelines/C...


Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (Arabic Version)
   • Preamble to CVD Prevention Guidelines...  


Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (English Version)
   • Preamble to CVD Prevention Guidelines...  


2019 ESC Guidelines of Management of Chronic Coronary Syndromes
https://www.escardio.org/Guidelines/C...


IMPROVE-IT trial. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
https://www.nejm.org/doi/full/10.1056...


ODYSSEY OUTCOMES trial. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
https://www.nejm.org/doi/full/10.1056...


REMINDER trial. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure
https://pubmed.ncbi.nlm.nih.gov/24780...


EPHESUS trial. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
https://www.nejm.org/doi/full/10.1056...


PARADISE-MI trial. Prospective ARNI versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI.
https://www.acc.org/Latest-in-Cardiol...


EMPAREG-OUTCOME trial. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
https://pubmed.ncbi.nlm.nih.gov/26378...


CANVAS trial. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
https://www.nejm.org/doi/full/10.1056...


DECLARE–TIMI 58. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
https://www.nejm.org/doi/full/10.1056...


EMMY trial. Empagliflozin in acute myocardial infarction.
https://academic.oup.com/eurheartj/ar...


SECURE trial. Polypill Strategy in Secondary Cardiovascular Prevention
https://www.nejm.org/doi/full/10.1056...